Vera Bril, MD, FRCPC

  • 2Articles
  • 18KReads1
  • 2022Active
  • 2Collaborators
  • 1Citations2

About

Vera Bril, MD, FRCPC, is affiliated with the Division of Neurology at the University of Toronto and University Health Network. Her publications focus on neurology, specifically exploring the role of antibodies and treatment strategies in myasthenia gravis. She has contributed to reviews on disease mechanisms and emerging therapies for generalized myasthenia gravis.

Publications

PCC
Role of Antibodies in Myasthenia Gravis Treatment
Academic Highlights

Role of Antibodies in Myasthenia Gravis Treatment

October 27, 2022

Symptoms and disease pathophysiology of myasthenia gravis (MG) vary considerably with each patient, and their individual preferences and priorities add to the need for individualized treatment of this autoimmune...
, ,
PCC
Role of Antibodies in Myasthenia Gravis Treatment
Webcast

Role of Antibodies in Myasthenia Gravis Treatment

May 24, 2022

Patients with generalized myasthenia gravis (gMG) receive multiple immunosuppressive therapies, but with incomplete suppression of IgG autoantibodies. Review this update on gMG to learn about novel therapies that can...
, ,

1 Read counts for articles published before 2020 may include some non-human traffic.

2 Citation counts provided by Crossref.

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Insightful. Evidence-based. Human-centered.

Listen Now
The Journal of Clinical Psychiatry podcast cover with Benjamin Brody, MD

Subscribe to read
more articles

Subscribe